Two retrospective immunohistochemical analyses also identified high nuclear NRF2 levels in PTC relative to benign lesions and normal tissue, indicating NRF2 pathway activation as a potential contributor to thyroid tumorigenesis (46, 47). Here, NFE2L2 is linked to thyroid gland disorder.